The rest of the 100 (in alphabetical order): Olivier Belenger, managing director, Theodorus
Olivier Belenger has been managing director of Theodorus, the fund allied to Université libre de Bruxelles (ULB), since 2003, illustrating a profound commitment to the innovation ecosystem of his alma mater – he has a master’s degree in law from ULB.
Theodorus focuses on medical technology, digital and engineering spinouts from ULB, typically investing $290,000 to $2.3m – though this will increase to $2.9m with a fourth fund that held its first close at $23m last month.
Recent investments include PharmaFluidics, a research diagnostics spinout from Dutch language institution Vrije Universiteit Brussel, that raised $9m in January this year in a round also featuring multi-university venture fund Qbic.
Belenger’s expertise stems from a two-decade career in venture capital. Theodorus has grown to four funds with a combined $63m under management. The first three funds have a portfolio of 31 companies, of which 26 are spinouts from ULB.
